De-Escalation of Antiplatelet Treatment in Patients with Myocardial Infarction Who Underwent Percutaneous Coronary Intervention: A Review of the Current Literature

In acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI), treatment with the P2Y(12) inhibitors ticagrelor or prasugrel is recommended over clopidogrel due to a better efficacy, albeit having more bleeding complication. These higher bleeding rates have provoked t...

Descripción completa

Detalles Bibliográficos
Autores principales: Claassens, Daniel MF, Sibbing, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563354/
https://www.ncbi.nlm.nih.gov/pubmed/32942754
http://dx.doi.org/10.3390/jcm9092983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563354/
https://www.ncbi.nlm.nih.gov/pubmed/32942754
http://dx.doi.org/10.3390/jcm9092983

Ejemplares similares